Stockscreener 앱 받기
35.82
0.64%
-0.23
시간 외 거래:
35.82
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Patterns Watch: What is the dividend yield of Crinetics Pharmaceuticals Inc2026 Retail & Weekly Top Gainers Alerts - baoquankhu1.vn
Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Stephen Betz Sells 10,612 Shares - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) CEO Sells $821,429.97 in Stock - MarketBeat
Crinetics Pharmaceuticals (CRNX) COO sells 9,911 shares for RSU taxes - Stock Titan
Crinetics (NASDAQ: CRNX) CSO sells shares to cover RSU tax - Stock Titan
Crinetics (CRNX) CEO discloses tax-related share sales under 10b5-1 plan - Stock Titan
CRNX (NASDAQ: CRNX) insider sells shares via 10b5-1 and option exercise - Stock Titan
Jim Cramer on Crinetics: “That’s a better spec than Aquestive” - MSN
[144] Crinetics Pharmaceuticals, Inc. SEC Filing - Stock Titan
Farallon Capital Management LLC Increases Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals announces $350M proposed public offering - MSN
Checkpoint Capital L.P. Purchases Shares of 260,000 Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Is Crinetics Pharmaceuticals (CRNX) Price Weakness Creating A Fresh Valuation Opportunity Now? - simplywall.st
Prosight Management LP Buys 30,561 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Is Crinetics Pharmaceuticals (CRNX) Pricing Reflect Its Sharp Swings And DCF Upside Potential - Yahoo Finance
Coelho Rogerio Vivaldi Sells 5,000 Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock - MarketBeat
Insider Sell: Coelho Vivaldi Sells 5,000 Shares of Crinetics Pha - GuruFocus
Crinetics Pharmaceuticals (CRNX) director sells 5,000 shares in planned trade - Stock Titan
Pier Capital LLC Has $3.12 Million Stake in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Volatility - Sahm
Crinetics Advances Atumelnant: Phase 1 Study Completion Sets Up Next Clinical Catalyst for CRNX - The Globe and Mail
Income Plays: Can Crinetics Pharmaceuticals Inc stock outperform in a bear market2026 Rallies & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Systematic review on acromegaly therapies receives journal approval, Crinetics Pharmaceuticals announces - Traders Union
(CRNX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
WINTON GROUP Ltd Takes Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Levels Update: Is Crinetics Pharmaceuticals Inc a stock for growth or value investorsMarket Activity Recap & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Rafferty Asset Management LLC Decreases Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf. - Yahoo Finance
Should value investors consider Crinetics Pharmaceuticals Inc2026 Year in Review & Verified Momentum Stock Ideas - baoquankhu1.vn
Will Crinetics Pharmaceuticals Inc. stock attract more institutional investorsInsider Buying & High Win Rate Trade Alerts - Naître et grandir
Crinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 Data - MSN
Crinetics Pharmaceuticals, Inc. (CRNX) Presents at TD Cowen 46th Annual Health Care ConferenceSlideshow - Seeking Alpha
Insider Trends: What is the dividend yield of Crinetics Pharmaceuticals IncJuly 2025 Pullbacks & High Conviction Investment Ideas - baoquankhu1.vn
American Century Companies Inc. Has $47.21 Million Stake in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Position Trimmed by GW&K Investment Management LLC - MarketBeat
Crinetics Pharma CFO Schilke sells $266k in stock By Investing.com - Investing.com Canada
Crinetics Pharma CFO Schilke sells $266k in stock - Investing.com
Insider Sell: Stephanie Okey Sells 3,000 Shares of Crinetics Pha - GuruFocus
Crinetics Pharmaceuticals (NASDAQ:CRNX) Director Stephanie Okey Sells 3,000 Shares - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) CFO Tobin Schilke Sells 6,713 Shares - MarketBeat
Crinetics (CRNX) director sells 3,000 shares under 10b5-1 plan - Stock Titan
Crinetics (NASDAQ: CRNX) CFO sells 6,713 shares to cover taxes - Stock Titan
CRNX: Strong launch, advancing pipeline, and EU expansion position for major growth in rare endocrine diseases - TradingView
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Auditor change at Crinetics (NASDAQ: CRNX) names PwC - Stock Titan
Crinetics Pharmaceuticals (CRNX) Stock Analysis: Unpacking a 105% Potential Upside for Growth Investors - DirectorsTalk Interviews
Why Crinetics Pharmaceuticals (CRNX) Is Down 7.1% After Deeper 2025 Loss And New US$207 Million Shelf Registration - Sahm
Does Crinetics Pharmaceuticals, Inc. (CRNX) Have Momentum? - AAII.com
CRNX: Analyst Maintains "Market Outperform" but Lowers Price Tar - GuruFocus
Citizens Jmp Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $96.00 - MarketBeat
Q4 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA) - The Globe and Mail
(CRNX) Risk Channels and Responsive Allocation - Stock Traders Daily
Crinetics Pharmaceuticals (NASDAQ:CRNX) Upgraded at Wall Street Zen - MarketBeat
Crinetics Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CRNX) 2026-02-27 - Seeking Alpha
Crinetics Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vanguard Group Inc. Sells 86,003 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Is Palsonfi Launch Momentum And ESOP Shelf Registration Altering The Investment Case For Crinetics (CRNX)? - Yahoo Finance
Crinetics Pharmaceuticals Inc (CRNX) Q4 2025 Earnings Call Highl - GuruFocus
Decoding Crinetics Pharmaceuticals Inc (CRNX): A Strategic SWOT Insight - GuruFocus
Crinetics Pharmaceuticals (CRNX) Reports Strong Q4 2025 Performa - GuruFocus
Crinetics Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Crinetics Pharmaceuticals Q4 2025 earnings beat forecasts - Investing.com
Crinetics (CRNX) Q4 2025 Earnings Call Transcript - The Globe and Mail
1.20%
0.06%
자본화:
|
볼륨(24시간):